KLTO
KLTO
NASDAQ · Biotechnology

Klotho Neurosciences Inc

$0.33
+0.05 (+18.66%)
Financial Highlights (FY 2025)
Revenue
2.95M
Net Income
-877,894
Gross Margin
33.4%
Profit Margin
-29.8%
Rev Growth
+6.0%
D/E Ratio
0.66
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 33.4% 33.4% 33.4%
Operating Margin -26.6% -26.8% -26.5%
Profit Margin -29.8% -27.0% -25.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.95M 2.89M 2.41M
Gross Profit 983.5K 965.1K 802.7K
Operating Income -783,085 -774,236 -638,224
Net Income -877,894 -779,690 -617,534
Gross Margin 33.4% 33.4% 33.4%
Operating Margin -26.6% -26.8% -26.5%
Profit Margin -29.8% -27.0% -25.7%
Rev Growth +6.0% +2.0% +0.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.78M 8.04M 6.27M
Total Equity 11.74M 12.17M 13.18M
D/E Ratio 0.66 0.66 0.48
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -957,867 -819,475 -798,278
Free Cash Flow -748,445 -747,364 -598,338